Results 1 to 10 of about 64,799 (309)

Cell-derived microparticles and the lung [PDF]

open access: yesEuropean Respiratory Review, 2016
Cell-derived microparticles are small (0.1–1 μm) vesicles shed by most eukaryotic cells upon activation or during apoptosis. Microparticles carry on their surface, and enclose within their cytoplasm, molecules derived from the parental cell, including ...
Dario Nieri   +5 more
doaj   +6 more sources

Correlations Between the Circulating Level of Cell-Derived Microparticles and Surgical Variables in Heart Valve Surgery with Cardiopulmonary Bypass [PDF]

open access: diamondJournal of Tehran University Heart Center, 2022
Background: Cell-derived microparticles (MPs) as membrane vesicles are procoagulant. They play a role in surgical hemostasis. In this study, the correlations between the circulating level of cell-derived MPs and surgical variables in heart valve surgery
Mehrnaz Abdolalian   +4 more
doaj   +3 more sources

Influence of red blood cell-derived microparticles upon vasoregulation. [PDF]

open access: greenBlood Transfus, 2017
Here we review recent data and the evolving understanding of the role of red blood cell-derived microparticles (RMPs) in normal physiology and in disease progression. Microparticles (MPs) are small membrane vesicles derived from various parent cell types.
Said AS, Doctor A.
europepmc   +4 more sources

Engineered Cell‐Derived Microparticles Bi2Se3/DOX@MPs for Imaging Guided Synergistic Photothermal/Low‐Dose Chemotherapy of Cancer [PDF]

open access: yesAdvanced Science, 2020
Cell‐derived microparticles, which are recognized as nanosized phospholipid bilayer membrane vesicles, have exhibited great potential to serve as drug delivery systems in cancer therapy.
Dongdong Wang   +14 more
doaj   +2 more sources

Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease

open access: goldHaematologica, 2009
Background Sickle cell disease is characterized by a hypercoagulable state as a result of multiple factors, including chronic hemolysis and circulating cell-derived microparticles. There is still no consensus on the cellular origin of such microparticles
Eduard J. van Beers   +7 more
doaj   +3 more sources

Apoptotic tumor cell-derived microparticles loading Napabucasin inhibit CSCs and synergistic immune therapy. [PDF]

open access: goldJ Nanobiotechnology, 2023
Jing B   +12 more
europepmc   +3 more sources

Membrane Cholesterol Enrichment of Red Blood Cell-Derived Microparticles Results in Prolonged Circulation. [PDF]

open access: greenACS Appl Bio Mater, 2022
Tang JC   +9 more
europepmc   +3 more sources

Release of Prometastatic Platelet-Derived Microparticles Induced by Breast Cancer Cells: A Novel Positive Feedback Mechanism for Metastasis [PDF]

open access: goldTH Open, 2017
Circulating platelets and platelet-derived microparticles are regulators of cancer metastasis. In this study, we show that breast cancer cells induce platelet aggregation and lead to the release of platelet-derived microparticles.
Marta Zarà   +8 more
doaj   +2 more sources

Cell-Derived Microparticles in Patients with Type 2 Diabetes Mellitus: a Systematic Review and Meta-Analysis [PDF]

open access: goldCellular Physiology and Biochemistry, 2016
Background/Aims: The aim of this study was to assess the association between circulating cell-derived microparticles (MPs) and type 2 diabetes mellitus (T2DM).
Sheyu Li   +11 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy